Logo image of ALTXC.PA

TXCOM (ALTXC.PA) Stock Fundamental Analysis

Europe - EPA:ALTXC - FR0010654087 - Common Stock

7.9 EUR
+0.05 (+0.64%)
Last: 10/22/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, ALTXC scores 3 out of 10 in our fundamental rating. ALTXC was compared to 0 industry peers in the Unkown industry. The financial health of ALTXC is average, but there are quite some concerns on its profitability. ALTXC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ALTXC had positive earnings in the past year.
In the past year ALTXC had a positive cash flow from operations.
ALTXC had positive earnings in each of the past 5 years.
In the past 5 years ALTXC always reported a positive cash flow from operatings.
ALTXC.PA Yearly Net Income VS EBIT VS OCF VS FCFALTXC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K 1M 1.5M 2M

1.2 Ratios

Industry RankSector Rank
ROA 8%
ROE 9.9%
ROIC 6.14%
ROA(3y)6.28%
ROA(5y)6.18%
ROE(3y)7.88%
ROE(5y)8.55%
ROIC(3y)7.24%
ROIC(5y)6.88%
ALTXC.PA Yearly ROA, ROE, ROICALTXC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ALTXC's Profit Margin has improved in the last couple of years.
In the last couple of years the Operating Margin of ALTXC has declined.
In the last couple of years the Gross Margin of ALTXC has grown nicely.
Industry RankSector Rank
OM 11.1%
PM (TTM) 11.08%
GM 50.85%
OM growth 3Y9.02%
OM growth 5Y-4.99%
PM growth 3Y0.32%
PM growth 5Y5.08%
GM growth 3Y16.4%
GM growth 5Y3.72%
ALTXC.PA Yearly Profit, Operating, Gross MarginsALTXC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALTXC is destroying value.
The number of shares outstanding for ALTXC remains at a similar level compared to 1 year ago.
ALTXC has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALTXC has an improved debt to assets ratio.
ALTXC.PA Yearly Shares OutstandingALTXC.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALTXC.PA Yearly Total Debt VS Total AssetsALTXC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

ALTXC has an Altman-Z score of 4.85. This indicates that ALTXC is financially healthy and has little risk of bankruptcy at the moment.
ALTXC has a debt to FCF ratio of 0.00. This is a very positive value and a sign of high solvency as it would only need 0.00 years to pay back of all of its debts.
A Debt/Equity ratio of 0.00 indicates that ALTXC is not too dependend on debt financing.
Although ALTXC does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.85
ROIC/WACC0.66
WACC9.28%
ALTXC.PA Yearly LT Debt VS Equity VS FCFALTXC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

A Current Ratio of 5.47 indicates that ALTXC has no problem at all paying its short term obligations.
A Quick Ratio of 4.79 indicates that ALTXC has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 5.47
Quick Ratio 4.79
ALTXC.PA Yearly Current Assets VS Current LiabilitesALTXC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

3. Growth

3.1 Past

ALTXC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.18%, which is quite impressive.
Measured over the past 5 years, ALTXC shows a small growth in Earnings Per Share. The EPS has been growing by 2.38% on average per year.
Looking at the last year, ALTXC shows a small growth in Revenue. The Revenue has grown by 2.55% in the last year.
ALTXC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.46% yearly.
EPS 1Y (TTM)69.18%
EPS 3Y-9.39%
EPS 5Y2.38%
EPS Q2Q%120.87%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-9.72%
Revenue growth 5Y-2.46%
Sales Q2Q%-4.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALTXC.PA Yearly Revenue VS EstimatesALTXC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTXC.PA Yearly EPS VS EstimatesALTXC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 0.2 0.4 0.6 0.8 1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.78, the valuation of ALTXC can be described as reasonable.
ALTXC is valuated cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.78
Fwd PE N/A
ALTXC.PA Price Earnings VS Forward Price EarningsALTXC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 6.21
EV/EBITDA -0.01
ALTXC.PA Per share dataALTXC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.68
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

ALTXC has a Yearly Dividend Yield of 4.52%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.35, ALTXC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.52%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTXC.PA Yearly Dividends per shareALTXC.PA Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2025 0.1 0.2 0.3

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
ALTXC.PA Yearly Income VS Free CF VS DividendALTXC.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K 1M 1.5M

More info and screens

TXCOM

EPA:ALTXC (10/22/2025, 7:00:00 PM)

7.9

+0.05 (+0.64%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners70.44%
Ins Owner ChangeN/A
Market Cap9.72M
Revenue(TTM)10.02M
Net Income(TTM)1.11M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.52%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.78
Fwd PE N/A
P/S 0.97
P/FCF 6.21
P/OCF 5.98
P/B 0.87
P/tB 0.87
EV/EBITDA -0.01
EPS(TTM)0.9
EY11.39%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.27
FCFY16.1%
OCF(TTM)1.32
OCFY16.73%
SpS8.15
BVpS9.12
TBVpS9.08
PEG (NY)N/A
PEG (5Y)3.68
Graham Number13.59
Profitability
Industry RankSector Rank
ROA 8%
ROE 9.9%
ROCE 9.58%
ROIC 6.14%
ROICexc 37.63%
ROICexgc 38.74%
OM 11.1%
PM (TTM) 11.08%
GM 50.85%
FCFM 15.61%
ROA(3y)6.28%
ROA(5y)6.18%
ROE(3y)7.88%
ROE(5y)8.55%
ROIC(3y)7.24%
ROIC(5y)6.88%
ROICexc(3y)32.55%
ROICexc(5y)29.22%
ROICexgc(3y)34.36%
ROICexgc(5y)31.87%
ROCE(3y)11.29%
ROCE(5y)10.74%
ROICexgc growth 3Y1.89%
ROICexgc growth 5Y2.27%
ROICexc growth 3Y5.49%
ROICexc growth 5Y5.73%
OM growth 3Y9.02%
OM growth 5Y-4.99%
PM growth 3Y0.32%
PM growth 5Y5.08%
GM growth 3Y16.4%
GM growth 5Y3.72%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 22.33%
Cap/Sales 0.61%
Interest Coverage 250
Cash Conversion 117.33%
Profit Quality 140.8%
Current Ratio 5.47
Quick Ratio 4.79
Altman-Z 4.85
F-Score7
WACC9.28%
ROIC/WACC0.66
Cap/Depr(3y)62.71%
Cap/Depr(5y)54.03%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.18%
EPS 3Y-9.39%
EPS 5Y2.38%
EPS Q2Q%120.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.55%
Revenue growth 3Y-9.72%
Revenue growth 5Y-2.46%
Sales Q2Q%-4.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.82%
EBIT growth 3Y-1.57%
EBIT growth 5Y-7.32%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.66%
FCF growth 3Y-5.98%
FCF growth 5Y27.02%
OCF growth 1Y12.3%
OCF growth 3Y-5.96%
OCF growth 5Y15.71%